Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Abdullahi Bello Umar"'
Autor:
Auwal Salisu Isa, Adamu Uzairu, Umar Mele Umar, Muhammad Tukur Ibrahim, Abdullahi Bello Umar, Iqrar Ahmad
Publikováno v:
Journal of Holistic Integrative Pharmacy, Vol 5, Iss 3, Pp 235-247 (2024)
Objective: The objective of this investigation is to create a trustworthy Quantitative Structure-Activity Relationship (QSAR) model that generates little to no side effects and is low-cost for treating colon cancer using experimental data obtained fr
Externí odkaz:
https://doaj.org/article/1fb37365417948e992cedf80d7fa13f0
Autor:
Abdulrahman Ibrahim Kubo, M.Sc, Adamu Uzairu, PhD, Ibrahim Tijjani Babalola, PhD, Muhammad Tukur Ibrahim, PhD, Abdullahi Bello Umar, PhD
Publikováno v:
Journal of Taibah University Medical Sciences, Vol 19, Iss 4, Pp 823-834 (2024)
الملخص: أهداف البحث: بحلول عام 2030، من المتوقع أن يتسبب سرطان البروستاتا في 1.7 مليون حالة جديدة و499 ألف حالة وفاة. أهداف هذا البحث هي إنشاء ن
Externí odkaz:
https://doaj.org/article/b11dd400e79347da87fedc5e58d63caa
Autor:
Sagiru Hamza Abdullahi, PhD, Adamu Uzairu, PhD, Gideon Adamu Shallangwa, PhD, Sani Uba, PhD, Abdullahi Bello Umar, PhD
Publikováno v:
Journal of Taibah University Medical Sciences, Vol 18, Iss 5, Pp 1018-1029 (2023)
المخلص: أهداف البحث: تصنف أورام الثدي على أنها أكثر أنواع الأورام التي تم تحديدها بين النساء على مستوى العالم مع أكثر من 1.7 مليون حالة سنوي
Externí odkaz:
https://doaj.org/article/c5029337a56d43499c7248d3bd897865
Autor:
Sagiru Hamza Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba, Abdullahi Bello Umar
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 35, Iss 1, Pp 1-26 (2023)
Abstract Background Breast cancer is the most common tumor among females globally. Its prevalence is growing around the world, and it is alleged to be the leading cause of cancer death. Approved anti-breast cancer drugs display several side effects a
Externí odkaz:
https://doaj.org/article/2a30fcd33e5a49008826835093c1bf39
Autor:
Sagiru Hamza Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba, Abdullahi Bello Umar
Publikováno v:
Bulletin of the National Research Centre, Vol 46, Iss 1, Pp 1-25 (2022)
Abstract Background In spite of the significant escalation in the depth of our conception and regulation of breast cancer over the past decades, the malady is still a serious community health challenge globally and poses a substantial tasks. Selectiv
Externí odkaz:
https://doaj.org/article/d246415fc63e4861aef65a77de6d4058
Publikováno v:
Bulletin of the National Research Centre, Vol 46, Iss 1, Pp 1-14 (2022)
Abstract Background Diabetes mellitus (DM) is one of the most defying health risk in the twenty-first century promoting a high rate of morbidity and mortality that could possibly increase if no intervention is in place. However, drugs for curing DM a
Externí odkaz:
https://doaj.org/article/f2f5ef971fab41a18763f078f2b57aae
Autor:
Sagiru Hamza Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba, Abdullahi Bello Umar
Publikováno v:
Bulletin of the National Research Centre, Vol 46, Iss 1, Pp 1-23 (2022)
Abstract Background Cancer is a major health threat especially in unindustrialized nations. It surpasses coronary diseases and takes the number one killer position as a result of different global wide influences. Among many breast cancer substrates,
Externí odkaz:
https://doaj.org/article/ecf20d5110a14bfea128a2efba75fd10
Publikováno v:
Bulletin of the National Research Centre, Vol 45, Iss 1, Pp 1-22 (2021)
Abstract Background The most well-known cause of cancer deaths identified in female is breast cancer. Several drugs approved by the food and drug administration (FDA) for the treatment of breast cancer may have adverse health effects. This research i
Externí odkaz:
https://doaj.org/article/daeebaa635e5476b8ab99dc698169439
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 22, Iss 1, Pp 1-15 (2021)
Abstract Background Melanoma cancer causes serious health problem worldwide because of its rapid invasion to other organs and lack of satisfactory chemotherapy. The pGI50 anticancer activity values of 70 compounds from the NCI (National Cancer Instit
Externí odkaz:
https://doaj.org/article/cca3eba4c4654fcfae199cfee4602356
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background V600E-BRAF is a major protein target involved in various types of human cancers. However, the acquired resistance of the V600E-BRAF kinase to the vemurafenib and the side effects of other identified drugs initiate the search for e
Externí odkaz:
https://doaj.org/article/2fa18381c4744ab5a3e2af007338e308